Trial intelligence / Profile preview

Vitamin D Supplementation for Cardiovascular Risk in Obesity

NCT02020694Phase 4Completed

Sponsor
Policlinico Gemelli
Start
Dec 2011
Primary completion
Dec 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 4 trial of vitamin d in obesity, insulin resistance (IR), sponsored by Policlinico Gemelli. Started Dec 2011; status: completed.

02

Drugs

vitamin d
03

Conditions

obesityinsulin resistance (IR)

Beyond the preview

Go deeper on NCT02020694.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02020694.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call